Multiple Myeloma

Showing NaN - NaN of 56

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (CC-5013 plus dexamethasone, Dexamethasone plus Placebo)

Completed
  • Multiple Myeloma
  • CC-5013 plus dexamethasone
  • Dexamethasone plus Placebo
  • Camperdown, New South Wales, Australia
  • +68 more
Sep 18, 2017

Multiple Myeloma Trial in Worldwide (Dasatinib, Bortezomib, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Orlando, Florida
  • +6 more
Feb 1, 2017

Multiple Myeloma Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo, Bortezomib)

Withdrawn
  • Multiple Myeloma
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Scottsdale, Arizona
  • +57 more
Oct 6, 2016

Multiple Myeloma Trial in Worldwide (A (Thalidomide + Dexamethasone), B (Placebo + Dexamethasone))

Completed
  • Multiple Myeloma
  • A (Thalidomide + Dexamethasone)
  • B (Placebo + Dexamethasone)
  • Hoover, Alabama
  • +98 more
Sep 9, 2015

Multiple Myeloma Trial in Bologna (Velcade, Thalidomide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Bologna, Italy
    AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
Jul 19, 2012

Multiple Myeloma Trial in Worldwide (bortezomib)

Completed
  • Multiple Myeloma
  • Berkeley, California
  • +92 more
Jan 12, 2012